Changeflow GovPing Pharma & Healthcare Influence of Clear Aligner Marginal Termination...
Routine Notice Added Final

Influence of Clear Aligner Marginal Termination Design on Subgingival Periodontal Microbiota: Split-Mouth Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered a clinical trial (NCT07533058) examining whether supragingival versus juxtagingival clear aligner edge designs affect subgingival periodontal microbiota in orthodontic patients. The split-mouth study will compare aligner edge designs covering 2mm of gum tissue versus those following the gumline exactly over 8 weeks of wear. The trial will enroll participants undergoing finishing phase orthodontic treatment to assess disease-associated bacteria levels.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a clinical trial on ClinicalTrials.gov studying the effect of clear aligner edge design on subgingival periodontal microbiota. The split-mouth study compares supragingival aligner edges (covering approximately 2mm of gum tissue) to juxtagingival edges (following the natural gumline) in patients undergoing finishing orthodontic treatment. Participants will wear both designs simultaneously for 8 weeks with fluid samples collected at baseline, 4 weeks, and 8 weeks.

For orthodontic practices and clear aligner manufacturers, this study represents informational research context rather than a compliance obligation. The findings may inform future product design or clinical practice regarding aligner edge specifications, but this trial registration imposes no regulatory requirements or reporting duties.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Influence of Finishing Clear Aligner Marginal Termination Design on Subgingival Periodontal Microbiota During Orthodontic Treatment: A Split-Mouth Study.

N/A NCT07533058 Kind: NA Apr 16, 2026

Abstract

The goal of this clinical trial is to learn whether the edge design of a finishing orthodontic clear aligner at the gumline affects the bacteria living in the groove between the tooth and the gum (the gingival sulcus) in patients undergoing the finishing phase of orthodontic treatment.

The main question it aims to answer is:

- Does a supragingival aligner edge design - which covers approximately 2 mm of gum tissue - lead to higher levels of disease-associated bacteria in the gingival sulcus compared to a juxtagingival edge design that follows the gumline exactly, after 4 and 8 weeks of aligner wear?

Researchers will compare the supragingival trimming-line design to the juxtagingival festooned design to see if covering gum tissue with the aligner edge creates conditions that favor the growth of anaerobic bacteria associated with gum disease.

Participants will:

  • Wear finishing clear aligners with both designs simultaneously - one design on the upper jaw and one on the lower jaw - for 8 weeks
  • Provide fluid samples from the gum groove at 3 visits: at the start of treatment (baseline), at 4 weeks, and at 8 weeks.

Two aligner edge designs are compared: a supragingival design, which has a straight horizontal edge positioned approximately 2 mm over the gumline, covering approximately 2 mm of gum tissue with direct contact but without entering the gum groove itself, and a juxtagingival design, which follows the natural scalloped shape of the gumline exactly, terminating a...

Conditions: Periodontal Diseases, Malocclusion, Oral Health

Interventions: CA Pro tri-layer finishing clear aligner (SCHEU-DENTAL GmbH)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07533058

Who this affects

Applies to
Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Clinical research Medical device research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!